Central Pacific Bank Trust Division Raises Stock Holdings in UnitedHealth Group Incorporated $UNH

Central Pacific Bank Trust Division boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 227.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,525 shares of the healthcare conglomerate’s stock after purchasing an additional 8,703 shares during the quarter. Central Pacific Bank Trust Division’s holdings in UnitedHealth Group were worth $4,325,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Norges Bank acquired a new position in shares of UnitedHealth Group during the second quarter worth $3,837,207,000. Berkshire Hathaway Inc purchased a new stake in UnitedHealth Group in the second quarter valued at about $1,572,193,000. Dodge & Cox increased its stake in UnitedHealth Group by 117.7% during the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock valued at $2,729,912,000 after purchasing an additional 4,730,192 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. Finally, Lone Pine Capital LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $528,273,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $341.46 on Tuesday. The company has a market cap of $309.31 billion, a PE ratio of 17.82, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The stock’s 50 day simple moving average is $339.49 and its 200-day simple moving average is $317.51.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the previous year, the firm posted $7.15 EPS. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. Piper Sandler reduced their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Bank of America increased their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Barclays upped their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Royal Bank Of Canada upped their target price on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.